Mild-to-moderate aortic stenosis not improved by lipid-lowering therapy: SEAS study.
出版信息
Cardiovasc J Afr. 2008 Sep-Oct;19(5):280-2.
PMID:18997993
Abstract
摘要
相似文献
1
Mild-to-moderate aortic stenosis not improved by lipid-lowering therapy: SEAS study.降脂治疗未能改善轻至中度主动脉瓣狭窄：SEAS研究。
Cardiovasc J Afr. 2008 Sep-Oct;19(5):280-2.
2
Impact of baseline severity of aortic valve stenosis on effect of intensive lipid lowering therapy (from the SEAS study).强化降脂治疗对主动脉瓣狭窄严重程度的影响（来自 SEAS 研究）。
Am J Cardiol. 2010 Dec 1;106(11):1634-9. doi: 10.1016/j.amjcard.2010.07.042. Epub 2010 Oct 14.
3
At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.ezetimibe治疗轻至中度主动脉瓣狭窄患者的首项临床终点试验“SEAS”在进行中：试验结果好坏参半，争议更大。
Heart Lung Circ. 2009 Oct;18(5):343-6. doi: 10.1016/j.hlc.2009.02.007. Epub 2009 Jul 7.
4
Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study.辛伐他汀与依折麦布治疗主动脉瓣狭窄（SEAS）研究的设计与基线特征
Am J Cardiol. 2007 Apr 1;99(7):970-3. doi: 10.1016/j.amjcard.2006.10.064. Epub 2007 Feb 15.
5
Calcific aortic stenosis.钙化性主动脉瓣狭窄
N Engl J Med. 2009 Jan 1;360(1):85; author reply 85-6. doi: 10.1056/NEJMc082192.
6
Ezetimibe and cancer--an uncertain association.依折麦布与癌症——一种不确定的关联。
N Engl J Med. 2008 Sep 25;359(13):1398-9. doi: 10.1056/NEJMe0807200. Epub 2008 Sep 2.
7
Ezetimibe revisited.
Med Lett Drugs Ther. 2008 Aug 25;50(1293):67-8.
8
Ezetimibe plus simvastatin cardiovascular outcomes study program.依折麦布与辛伐他汀心血管结局研究项目
Expert Rev Cardiovasc Ther. 2008 Jan;6(1):17-25. doi: 10.1586/14779072.6.1.17.
9
Aortic stenosis and lipids: does intervention work?主动脉瓣狭窄与血脂：干预有效吗？
Curr Opin Cardiol. 2010 Jul;25(4):379-84. doi: 10.1097/HCO.0b013e3283393c9b.
10
Incidence of cancer and mortality in patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial.辛伐他汀与依折麦布治疗主动脉瓣狭窄（SEAS）试验中患者的癌症发病率和死亡率
Am J Cardiol. 2014 Nov 15;114(10):1518-22. doi: 10.1016/j.amjcard.2014.08.016. Epub 2014 Aug 27.
Zotero 插件